Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Disruptive Innovation in Dialysis and Medical Device Manufacturing

Disruptors come in many flavors and innovate countless industries. Healthcare is one space that welcomes technology disruption, where advancements in medical devices can improve the lives of many. Outset Medical is one such medical device manufacturer seeking to transform the dialysis experience. Marc Nash, VP of Manufacturing at Outset Medical, joined DisruptED’s Ron Stefanski…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from DisruptED on MarketScale.

Share

Disruptors come in many flavors and innovate countless industries. Healthcare is one space that welcomes technology disruption, where advancements in medical devices can improve the lives of many. Outset Medical is one such medical device manufacturer seeking to transform the dialysis experience.

Marc Nash, VP of Manufacturing at Outset Medical, joined DisruptED’s Ron Stefanski to share his company’s exciting work to improve the dialysis process and experience. A dialysis patient must endure a cumbersome lifelong process that creates a burden for them and their family, not to mention the physical toll it carries on the body.

“We wanted to see how we could give patients back their life,” Nash said. “How could they take more control over what they could do? So, we created a product called Tablo, and we’re now in the home market.”

Making dialysis available in a patient’s home is a critical first step in that journey to give patients their freedom back. With a typical dialysis treatment taking five hours and up to three times a week, not traveling to a healthcare facility to get treatment can be a game-changer.

“Imagine if you wanted to do dialysis at 7 p.m. to 10 p.m. or 11 p.m., most clinics are not going to be open during these times,” Nash said. “Where if you’re in the comfort of your house, you can go to work, take care of the kids, and then go about your dialysis.”

Nash said it comes down to the people within Outset Medical to make strides in dialysis.

“When I hire within my organization, I’m looking for attitude. I want to see the people that have grit and determination. Most people are not going to come to my organization knowing dialysis; they’re going to come from either the Medtech space, aerospace, they’re going to come from automotive, or tech, and I’m going to have to teach them dialysis. That’s the easy part. What’s hard to teach is grit.”

DisruptED

Part of this channel

DisruptED

Education, workforce, and manufacturing futures with Ron J. Stefanski.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512